📷 Image: Flickr (CC)
Business
Indoco Remedies' Goa Facility Passes UKMHRA cGMP Inspection
✍️ business-standard.com
🗓 10 Sep 2026, 03:34 PM
👁 6
Indoco Remedies' manufacturing unit in Goa has successfully cleared a cGMP inspection by the UK's Medicines and Healthcare products Regulatory Agency (UKMHRA). The approval confirms the plant meets international quality standards for pharmaceutical production.
Indoco Remedies, one of India’s leading generic pharmaceutical manufacturers, has had its Goa-based production facility inspected by the UK Medicines and Healthcare products Regulatory Agency (UKMHRA). The inspection focused on the plant’s compliance with current Good Manufacturing Practice (cGMP) standards, which govern the quality, safety and efficacy of medicines.
The UKMHRA audit concluded that the Goa plant meets all required cGMP criteria, affirming that its processes, facilities and documentation adhere to stringent international norms. This clearance is a significant milestone for Indoco, potentially easing the company’s entry into the UK market and other global markets that require UKMHRA approval.
Industry analysts note that such approvals can enhance a company’s credibility among international partners and investors, and may lead to increased export opportunities. Indoco has previously highlighted its commitment to quality and regulatory compliance as a cornerstone of its growth strategy.
The UKMHRA audit concluded that the Goa plant meets all required cGMP criteria, affirming that its processes, facilities and documentation adhere to stringent international norms. This clearance is a significant milestone for Indoco, potentially easing the company’s entry into the UK market and other global markets that require UKMHRA approval.
Industry analysts note that such approvals can enhance a company’s credibility among international partners and investors, and may lead to increased export opportunities. Indoco has previously highlighted its commitment to quality and regulatory compliance as a cornerstone of its growth strategy.